logo

Thrombotic Thrombocytopenic Pupura (TTP) - DAP A

Complete · United Kingdom

Source: Open Contracting Data Standard (OCDS)

Tender
Complete

Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder with rapid onset, that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. The condition can be difficult to diagnose because initial presentation can be non-specific, and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includ

Status
Closed
Sector
Education
Location
United Kingdom
Updated
3 Nov 2026
Source
Open Contracting Data Standard (OCDS)

ConstructChat

Ask ConstructChat about Thrombotic Thrombocytopenic Pupura (TTP) - DAP A

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Thrombotic Thrombocytopenic Pupura (TTP) - DAP A” is a tender record in Taiyo, linked to the Education sector. It is issued for works, goods, or services related to United Kingdom.

Participants

Not available for this record.

Status

Original status

complete

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder with rapid onset, that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. <br/>The condition can be difficult to diagnose because initial presentation can be non-specific, and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects adults. Children are treated in paediatric haematology centres with support from the adult specialists. Specialist aftercare is also required. Services are required to have a programme of outreach and education to improve timely diagnosis and referral. There is a small population with a congenital form of the disease who require ongoing treatment and monitoring. <br/>Patients need to be able to access specialist care with 24/7 access to apheresis and a specialist team. Patients need to start in treatment within 4/8 hours of a referral to the specialist centre.

Location

Country

United Kingdom (UK)

Source

Source

Open Contracting Data Standard (OCDS)

URL

More Details

Record type

Tender

Sector

Education

Article published date

2026-06-02

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender